Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
12.43
+0.61 (5.16%)
May 20, 2025, 4:00 PM - Market closed
Zymeworks Employees
As of December 31, 2024, Zymeworks had 286 total employees, including 280 full-time and 6 part-time employees. The number of employees increased by 8 or 2.88% compared to the previous year.
Employees
286
Change (1Y)
8
Growth (1Y)
2.88%
Revenue / Employee
$326,517
Profits / Employee
-$397,476
Market Cap
866.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ZYME News
- 2 hours ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 1 day ago - Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference - GlobeNewsWire
- 12 days ago - Zymeworks Inc. (ZYME) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 22 days ago - Zymeworks: A Strong Buy With Newly-Approved Cancer Drug, Excellent Financials, And Expansive Pipeline - Seeking Alpha
- 22 days ago - Zymeworks: Poised For Growth With Platform Validation - Seeking Alpha
- 25 days ago - Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - GlobeNewsWire
- 4 weeks ago - Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - GlobeNewsWire